At a glance
ClinicalIndex Comparison RecordN/ACompleted· 91 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Measurement and Analysis of Macular Retinal Pigment Epithelium (RPE) Elevations With Cirrus HD-OCT vs. Color Fundus Photography
In Brief
An observational study for Drusen Stage Macular Degeneration. Completed, enrolled 91 participants across 4 sites.
Detailed Summary
The objective of this study is to compare the areas designated as elevated retinal pigment epithelium (RPE) by the Cirrus HD-OCT versus those designated as drusen on color fundus photographs (CFPs).
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsDrusen Stage Macular Degeneration
CountriesUnited States
CollaboratorsDataMed Devices Inc.
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartNov 2010
First PostedJan 2011
Primary CompletionFeb 2011
TodayJul 2026
First PostedJan 7, 2011
Enrollment StartNov 1, 2010
Primary CompletionFeb 1, 2011
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 15.5 years ago